hrp0097p1-290 | GH and IGFs | ESPE2023
van Dommelen Paula
, Arnaud Lilian
, Zucchiatti Chantal
, Koledova Ekaterina
Background: Treatment for growth disorders requires daily injections of recombinant human growth hormone (r-hGH) over multiple years, and automated devices may help in this regard. The ability to adjust injection device settings, which are pre-set as default unless changed by healthcare professionals, may improve patient comfort and needle anxiety and thereby improve adherence.Aim: To study the association between inject...